🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Drug Acquiring Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to message these accounts privately for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Some professionals stated the popularity for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the platform has taken down problematic material and banned associated hashtags and query recommendations. The company said it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also found groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, positive reviews and detailed instructions for preparing or administering at home.

After minutes of entering one community, a vendor shared contact information, where the majority of transactions take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.

Product Details and Costs

Inside these communities, posts display black plastic packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When asked how much time a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram stated it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has previously seen patients injured by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject users to possibly serious health risks”.